BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 15716155)

  • 1. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.
    Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM
    Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism.
    Moustafa AA; Sherman SJ; Frank MJ
    Neuropsychologia; 2008 Nov; 46(13):3144-56. PubMed ID: 18687347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
    Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
    Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease.
    Shohamy D; Myers CE; Grossman S; Sage J; Gluck MA
    Behav Brain Res; 2005 Jan; 156(2):191-9. PubMed ID: 15582105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease.
    Fern-Pollak L; Whone AL; Brooks DJ; Mehta MA
    Neuropsychologia; 2004; 42(14):1917-26. PubMed ID: 15381022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.
    Cools R
    Neurosci Biobehav Rev; 2006; 30(1):1-23. PubMed ID: 15935475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficit of short-term memory in newly diagnosed untreated parkinsonian patients: reversal after L-dopa therapy.
    Marini P; Ramat S; Ginestroni A; Paganini M
    Neurol Sci; 2003 Oct; 24(3):184-5. PubMed ID: 14598078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic effects on cognitive performance in patients with Parkinson's disease.
    Lange KW; Paul GM; Naumann M; Gsell W
    J Neural Transm Suppl; 1995; 46():423-32. PubMed ID: 8821078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of verbal working memory in patients with Parkinson's disease.
    Gilbert B; Belleville S; Bherer L; Chouinard S
    Neuropsychology; 2005 Jan; 19(1):106-14. PubMed ID: 15656768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential role of dopamine in emotional attention and memory: evidence from Parkinson's disease.
    Hälbig TD; Assuras S; Creighton J; Borod JC; Tse W; Frisina PG; Voustianiouk A; Gracies JM; Olanow CW
    Mov Disord; 2011 Aug; 26(9):1677-83. PubMed ID: 21638322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Set-shifting and the on-line processing of relative clauses in Parkinson's disease: results from a novel eye-tracking method.
    Hochstadt J
    Cortex; 2009 Sep; 45(8):991-1011. PubMed ID: 19473654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
    Mongeon D; Blanchet P; Messier J
    Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of internal clock and memory disorders on duration reproductions and duration productions in patients with Parkinson's disease.
    Perbal S; Deweer B; Pillon B; Vidailhet M; Dubois B; Pouthas V
    Brain Cogn; 2005 Jun; 58(1):35-48. PubMed ID: 15878725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attentional cueing reverses deficits in spatial working memory task performance in chronic low dose MPTP-treated monkeys.
    Decamp E; Tinker JP; Schneider JS
    Behav Brain Res; 2004 Jul; 152(2):259-62. PubMed ID: 15196793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
    Tomer R; Aharon-Peretz J; Tsitrinbaum Z
    Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute tryptophan depletion on cognition, memory and motor performance in Parkinson's disease.
    Scholtissen B; Verhey FR; Adam JJ; Prickaerts J; Leentjens AF
    J Neurol Sci; 2006 Oct; 248(1-2):259-65. PubMed ID: 16756999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of the prefrontal cortex and basal ganglia to set shifting.
    Ravizza SM; Ciranni MA
    J Cogn Neurosci; 2002 Apr; 14(3):472-83. PubMed ID: 11970806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Parkinson's disease and dopamine on digit span measures of working memory.
    Grogan JP; Knight LE; Smith L; Irigoras Izagirre N; Howat A; Knight BE; Bickerton A; Isotalus HK; Coulthard EJ
    Psychopharmacology (Berl); 2018 Dec; 235(12):3443-3450. PubMed ID: 30315362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of working memory components in planning performance of individuals with Parkinson's disease.
    Altgassen M; Phillips L; Kopp U; Kliegel M
    Neuropsychologia; 2007 Jun; 45(10):2393-7. PubMed ID: 17382361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine and memory function in Parkinson's disease.
    Mohr E; Fabbrini G; Williams J; Schlegel J; Cox C; Fedio P; Chase TN
    Mov Disord; 1989; 4(2):113-20. PubMed ID: 2543918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.